|
Andreu-Cayuelas JM, Pastor-Pérez FJ, Puche CM, Mateo-Martínez A, García-Alberola A, Flores-Blanco PJ, Valdés M, Lip GY, Roldán V, Manzano-Fernández S. Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure. Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):134-40. doi: 10.1016/j.rec.2015.06.021. Epub 2015 Oct 23. PubMed PMID: 26607030.
AÑO: 2016; IF: 4.485
|
26607030
|
Álvarez-García J, Ferrero-Gregori A, Puig T, Vázquez R, Delgado J, Pascual-Figal D, Alonso-Pulpón L, González-Juanatey JR, Rivera M, Worner F, Bardají A, Cinca J; investigators of the Spanish Heart Failure Network (REDINSCOR).. A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE. Eur J Heart Fail. 2015 Aug;17(8):818-27. doi: 10.1002/ejhf.287. PubMed PMID: 26011392; PubMed Central PMCID: PMC5032982.
AÑO: 2015; IF: 5.135
|
|
Pastor Quirante FA, Pastor-Pérez FJ, Manzano-Fernández S, Rivas NL, Pérez PP, Hernández JP, Gimeno-Blanes JR. Unexpected autopsy findings after sudden cardiac death: cardiovascular myxoedema and endocardial fibroelastosis. Int J Cardiol. 2015 Mar 1;182:281-3. doi: 10.1016/j.ijcard.2014.12.156. PubMed PMID: 25585372.
AÑO: 2015; IF: 4.638
|
|
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. PubMed PMID: 30145929.
AÑO: 2018; IF: 70.67
|
|
Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world. Eur J Heart Fail. 2019 Nov;21(11):1383-1397. doi: 10.1002/ejhf.1532. Epub 2019 Jun 18. PubMed PMID: 31132222.
AÑO: 2019; IF: 11.627
|